UK authorizes Merck's COVID treatment
The United Kingdom has authorized Merck's COVID-19 treatment, becoming the first country in the world to do so.
Clinical studies suggest Merck's COVID-19 pill, molnupiravir, may reduce the ability of the virus to multiply in the body, thereby preventing hospitalization or death in patients with mild to moderate COVID-19.
The UK's Medicines + Healthcare products Regulatory Agency said the antiviral drug was found to be safe and effective following a stringent review of the available evidence.
-ABC News' Christine Theodorou